CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.
Identifieur interne : 000515 ( PubMed/Corpus ); précédent : 000514; suivant : 000516CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.
Auteurs : Peter W. Horby ; Karen L. Laurie ; Benjamin J. Cowling ; Othmar G. Engelhardt ; Katharine Sturm-Ramirez ; Jose L. Sanchez ; Jacqueline M. Katz ; Timothy M. Uyeki ; John Wood ; Maria D. Van KerkhoveSource :
- Influenza and other respiratory viruses [ 1750-2659 ] ; 2017.
English descriptors
- KwdEn :
- MESH :
- epidemiology : Influenza, Human.
- immunology : Influenza, Human.
- prevention & control : Pandemics.
- statistics & numerical data : Pandemics.
- Case-Control Studies, Cohort Studies, Cross-Sectional Studies, Humans, Research Design, Seroepidemiologic Studies.
Abstract
Population-based serologic studies are a vital tool for understanding the epidemiology of influenza and other respiratory viruses, including the early assessment of the transmissibility and severity of the 2009 influenza pandemic, and Middle East respiratory syndrome coronavirus. However, interpretation of the results of serologic studies has been hampered by the diversity of approaches and the lack of standardized methods and reporting.
DOI: 10.1111/irv.12411
PubMed: 27417916
Links to Exploration step
pubmed:27417916Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.</title><author><name sortKey="Horby, Peter W" sort="Horby, Peter W" uniqKey="Horby P" first="Peter W" last="Horby">Peter W. Horby</name><affiliation><nlm:affiliation>Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Laurie, Karen L" sort="Laurie, Karen L" uniqKey="Laurie K" first="Karen L" last="Laurie">Karen L. Laurie</name><affiliation><nlm:affiliation>WHO Collaborating Centre for Reference and Research on Influenza, at the Peter Doherty Institute for Infectious Diseases, Melbourne, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Cowling, Benjamin J" sort="Cowling, Benjamin J" uniqKey="Cowling B" first="Benjamin J" last="Cowling">Benjamin J. Cowling</name><affiliation><nlm:affiliation>WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.</nlm:affiliation></affiliation></author><author><name sortKey="Engelhardt, Othmar G" sort="Engelhardt, Othmar G" uniqKey="Engelhardt O" first="Othmar G" last="Engelhardt">Othmar G. Engelhardt</name><affiliation><nlm:affiliation>National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Sturm Ramirez, Katharine" sort="Sturm Ramirez, Katharine" uniqKey="Sturm Ramirez K" first="Katharine" last="Sturm-Ramirez">Katharine Sturm-Ramirez</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Sanchez, Jose L" sort="Sanchez, Jose L" uniqKey="Sanchez J" first="Jose L" last="Sanchez">Jose L. Sanchez</name><affiliation><nlm:affiliation>Armed Forces Health Surveillance Center (AFHSC) and Cherokee Nation Technology Solutions, Inc, Silver Spring, MD, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Katz, Jacqueline M" sort="Katz, Jacqueline M" uniqKey="Katz J" first="Jacqueline M" last="Katz">Jacqueline M. Katz</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Uyeki, Timothy M" sort="Uyeki, Timothy M" uniqKey="Uyeki T" first="Timothy M" last="Uyeki">Timothy M. Uyeki</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Wood, John" sort="Wood, John" uniqKey="Wood J" first="John" last="Wood">John Wood</name><affiliation><nlm:affiliation>National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Van Kerkhove, Maria D" sort="Van Kerkhove, Maria D" uniqKey="Van Kerkhove M" first="Maria D" last="Van Kerkhove">Maria D. Van Kerkhove</name><affiliation><nlm:affiliation>Center for Global Health, Institut Pasteur, Paris, France.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:27417916</idno><idno type="pmid">27417916</idno><idno type="doi">10.1111/irv.12411</idno><idno type="wicri:Area/PubMed/Corpus">000515</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000515</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.</title><author><name sortKey="Horby, Peter W" sort="Horby, Peter W" uniqKey="Horby P" first="Peter W" last="Horby">Peter W. Horby</name><affiliation><nlm:affiliation>Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Laurie, Karen L" sort="Laurie, Karen L" uniqKey="Laurie K" first="Karen L" last="Laurie">Karen L. Laurie</name><affiliation><nlm:affiliation>WHO Collaborating Centre for Reference and Research on Influenza, at the Peter Doherty Institute for Infectious Diseases, Melbourne, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Cowling, Benjamin J" sort="Cowling, Benjamin J" uniqKey="Cowling B" first="Benjamin J" last="Cowling">Benjamin J. Cowling</name><affiliation><nlm:affiliation>WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.</nlm:affiliation></affiliation></author><author><name sortKey="Engelhardt, Othmar G" sort="Engelhardt, Othmar G" uniqKey="Engelhardt O" first="Othmar G" last="Engelhardt">Othmar G. Engelhardt</name><affiliation><nlm:affiliation>National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Sturm Ramirez, Katharine" sort="Sturm Ramirez, Katharine" uniqKey="Sturm Ramirez K" first="Katharine" last="Sturm-Ramirez">Katharine Sturm-Ramirez</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Sanchez, Jose L" sort="Sanchez, Jose L" uniqKey="Sanchez J" first="Jose L" last="Sanchez">Jose L. Sanchez</name><affiliation><nlm:affiliation>Armed Forces Health Surveillance Center (AFHSC) and Cherokee Nation Technology Solutions, Inc, Silver Spring, MD, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Katz, Jacqueline M" sort="Katz, Jacqueline M" uniqKey="Katz J" first="Jacqueline M" last="Katz">Jacqueline M. Katz</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Uyeki, Timothy M" sort="Uyeki, Timothy M" uniqKey="Uyeki T" first="Timothy M" last="Uyeki">Timothy M. Uyeki</name><affiliation><nlm:affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Wood, John" sort="Wood, John" uniqKey="Wood J" first="John" last="Wood">John Wood</name><affiliation><nlm:affiliation>National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK.</nlm:affiliation></affiliation></author><author><name sortKey="Van Kerkhove, Maria D" sort="Van Kerkhove, Maria D" uniqKey="Van Kerkhove M" first="Maria D" last="Van Kerkhove">Maria D. Van Kerkhove</name><affiliation><nlm:affiliation>Center for Global Health, Institut Pasteur, Paris, France.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Influenza and other respiratory viruses</title><idno type="eISSN">1750-2659</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Case-Control Studies</term><term>Cohort Studies</term><term>Cross-Sectional Studies</term><term>Humans</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (immunology)</term><term>Pandemics (prevention & control)</term><term>Pandemics (statistics & numerical data)</term><term>Research Design</term><term>Seroepidemiologic Studies</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Pandemics</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Pandemics</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Case-Control Studies</term><term>Cohort Studies</term><term>Cross-Sectional Studies</term><term>Humans</term><term>Research Design</term><term>Seroepidemiologic Studies</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Population-based serologic studies are a vital tool for understanding the epidemiology of influenza and other respiratory viruses, including the early assessment of the transmissibility and severity of the 2009 influenza pandemic, and Middle East respiratory syndrome coronavirus. However, interpretation of the results of serologic studies has been hampered by the diversity of approaches and the lack of standardized methods and reporting.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27417916</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1750-2659</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>01</Month></PubDate></JournalIssue><Title>Influenza and other respiratory viruses</Title><ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation></Journal><ArticleTitle>CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.</ArticleTitle><Pagination><MedlinePgn>2-14</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/irv.12411</ELocationID><Abstract><AbstractText Label="BACKGROUND">Population-based serologic studies are a vital tool for understanding the epidemiology of influenza and other respiratory viruses, including the early assessment of the transmissibility and severity of the 2009 influenza pandemic, and Middle East respiratory syndrome coronavirus. However, interpretation of the results of serologic studies has been hampered by the diversity of approaches and the lack of standardized methods and reporting.</AbstractText><AbstractText Label="OBJECTIVE">The objective of the CONSISE ROSES-I statement was to improve the quality and transparency of reporting of influenza seroepidemiologic studies and facilitate the assessment of the validity and generalizability of published results.</AbstractText><AbstractText Label="METHODS">The ROSES-I statement was developed as an expert consensus of the CONSISE epidemiology and laboratory working groups. The recommendations are presented in the familiar format of a reporting guideline. Because seroepidemiologic studies are a specific type of observational epidemiology study, the ROSES-I statement is built upon the STROBE guidelines. As such, the ROSES-I statement should be seen as an extension of the STROBE guidelines.</AbstractText><AbstractText Label="RESULTS">The ROSES-I statement presents 42 items that can be used as a checklist of the information that should be included in the results of published seroepidemiologic studies, and which can also serve as a guide to the items that need to be considered during study design and implementation.</AbstractText><AbstractText Label="CONCLUSIONS">We hope that the ROSES-I statement will contribute to improving the quality of reporting of seroepidemiologic studies.</AbstractText><CopyrightInformation>© 2016 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Horby</LastName><ForeName>Peter W</ForeName><Initials>PW</Initials><AffiliationInfo><Affiliation>Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laurie</LastName><ForeName>Karen L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>WHO Collaborating Centre for Reference and Research on Influenza, at the Peter Doherty Institute for Infectious Diseases, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cowling</LastName><ForeName>Benjamin J</ForeName><Initials>BJ</Initials><Identifier Source="ORCID">0000-0002-6297-7154</Identifier><AffiliationInfo><Affiliation>WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engelhardt</LastName><ForeName>Othmar G</ForeName><Initials>OG</Initials><AffiliationInfo><Affiliation>National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sturm-Ramirez</LastName><ForeName>Katharine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanchez</LastName><ForeName>Jose L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Armed Forces Health Surveillance Center (AFHSC) and Cherokee Nation Technology Solutions, Inc, Silver Spring, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katz</LastName><ForeName>Jacqueline M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uyeki</LastName><ForeName>Timothy M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wood</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Kerkhove</LastName><ForeName>Maria D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Center for Global Health, Institut Pasteur, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>CONSISE Steering Committee</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>089275/Z/09/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>U01 GM110721</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>093488/Z/10/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/J008761/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>106491/ Z/14/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>U54 GM088558</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016446">Consensus Development Conference</PublicationType><PublicationType UI="D016431">Guideline</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Influenza Other Respir Viruses</MedlineTA><NlmUniqueID>101304007</NlmUniqueID><ISSNLinking>1750-2640</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="Y">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="Y">Seroepidemiologic Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>06</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27417916</ArticleId><ArticleId IdType="doi">10.1111/irv.12411</ArticleId><ArticleId IdType="pmc">PMC5155648</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Influenza Other Respir Viruses. 2013 May;7(3):231-4</Citation><ArticleIdList><ArticleId IdType="pubmed">23280042</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Mar 27;375(9720):1100-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20096450</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology. 2013 Nov;24(6):830-41</Citation><ArticleIdList><ArticleId IdType="pubmed">24045719</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Nov 12;361(20):1945-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19745214</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2007 Oct 20;370(9596):1453-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18064739</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2010 Mar 24;7(3):e1000251</Citation><ArticleIdList><ArticleId IdType="pubmed">20352064</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2009 Feb 3;6(2):e22</Citation><ArticleIdList><ArticleId IdType="pubmed">19192942</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2009 Aug;15(8):1252-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19751587</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev Biol (Basel). 2003;115:63-73</Citation><ArticleIdList><ArticleId IdType="pubmed">15088777</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2013 May;56(9):1206-12</Citation><ArticleIdList><ArticleId IdType="pubmed">23386633</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 1999 Apr;37(4):937-43</Citation><ArticleIdList><ArticleId IdType="pubmed">10074505</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2010 Mar 27;375(9720):1062-3</Citation><ArticleIdList><ArticleId IdType="pubmed">20096449</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2013 Aug 15;208(4):554-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23687225</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2011 Oct;8(10):e1001103</Citation><ArticleIdList><ArticleId IdType="pubmed">21990967</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol Methods. 2006 Mar;132(1-2):113-20</Citation><ArticleIdList><ArticleId IdType="pubmed">16271401</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Apr 22;9(4):e95612</Citation><ArticleIdList><ArticleId IdType="pubmed">24755627</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2014 Jan 15;209(2):265-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23935201</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2007 May;1(3):105-12</Citation><ArticleIdList><ArticleId IdType="pubmed">19453415</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2014 Jan 09;19(1):</Citation><ArticleIdList><ArticleId IdType="pubmed">24434176</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2014 Apr 03;10(4):e1004054</Citation><ArticleIdList><ArticleId IdType="pubmed">24699693</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011;6(11):e26427</Citation><ArticleIdList><ArticleId IdType="pubmed">22110586</ArticleId></ArticleIdList></Reference><Reference><Citation>Wkly Epidemiol Rec. 2010 Jun 11;85(24):229-35</Citation><ArticleIdList><ArticleId IdType="pubmed">20545056</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Res Methodol. 2010 Mar 08;10:18</Citation><ArticleIdList><ArticleId IdType="pubmed">20210985</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011 Feb 23;6(2):e17074</Citation><ArticleIdList><ArticleId IdType="pubmed">21373639</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza Other Respir Viruses. 2013 Sep;7(5):872-86</Citation><ArticleIdList><ArticleId IdType="pubmed">23331969</ArticleId></ArticleIdList></Reference><Reference><Citation>Viral Immunol. 2011 Jun;24(3):221-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21668363</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2010 Nov 15;51(10):1184-91</Citation><ArticleIdList><ArticleId IdType="pubmed">20964521</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2011 Dec;85(23):12455-63</Citation><ArticleIdList><ArticleId IdType="pubmed">21957281</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2009 Nov 4;302(17):1872-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19822627</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2011 Mar 24;6(3):e17908</Citation><ArticleIdList><ArticleId IdType="pubmed">21455307</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(12):e48229</Citation><ArticleIdList><ArticleId IdType="pubmed">23284613</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2012;8(12):e1003061</Citation><ArticleIdList><ArticleId IdType="pubmed">23271967</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2013 May;56(9):1213-5</Citation><ArticleIdList><ArticleId IdType="pubmed">23386632</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2011 Nov;15(11):e781-6</Citation><ArticleIdList><ArticleId IdType="pubmed">21855383</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2009 Nov 4;302(17):1880-7</Citation><ArticleIdList><ArticleId IdType="pubmed">19822626</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 2011 Aug 15;174(4):468-78</Citation><ArticleIdList><ArticleId IdType="pubmed">21719743</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2012 Jan 5;30(2):210-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22100887</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2012 Mar 23;335(6075):1463</Citation><ArticleIdList><ArticleId IdType="pubmed">22362880</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000515 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000515 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:27417916
|texte= CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:27417916" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |